The effect on mortality of antipyretics in the treatment of influenza infection: Systematic review and meta-analyis

Journal of the Royal Society of Medicine

Volumn 103, Issue 10, 2010, Pages 403-411

  Eyers, Sally ^a,b,c   Weatherall, Mark ^b,c   Shirtcliffe, Philippa ^a,b   Perrin, Kyle ^a,b   Beasley, Richard ^a,b,d  

^a MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND   (New Zealand)

^b CAPITAL AND COAST DISTRICT HEALTH BOARD   (New Zealand)

^c UNIVERSITY OF OTAGO WELLINGTON   (New Zealand)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIPYRETIC AGENT; DICLOFENAC; IBUPROFEN; INDOMETACIN; PARACETAMOL; ANALGESIC AGENT;

ARTICLE; COCHRANE LIBRARY; DRUG EFFECT; DRUG USE; EMBASE; INFLUENZA; MEDLINE; MORTALITY; NONHUMAN; RISK ASSESSMENT; SYSTEMATIC REVIEW; ANIMAL; DISEASE MODEL; HUMAN; META ANALYSIS; ORTHOMYXOVIRUS INFECTION; REVIEW;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANIMALS; ASPIRIN; DICLOFENAC; DISEASE MODELS, ANIMAL; HUMANS; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE INFECTIONS;

EID: 78049392359     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1258/jrsm.2010.090441     Document Type: Article

References (50)

1. Centers for Disease Control and Prevention. Interim Guidance for Novel H1N1 Flu (Swine Flu). Atlanta, GA: CDC; 2009. See www.cdc.gov
2. Department of Health, British Thoracic Society, British Infection Society, Health Protection Agency. Clinical guidelines for patients with an influenza like illness during an influenza pandemic. London: Department of Health; 2006
3. Mackowiak PA. What we do when we suppress fever. Curr Infect Dis Rep 2005;7:1-4
4. Russell FM, Shann F, Curtis N, Mulholland K. Evidence on the use of paracetamol in febrile children. Bull World Health Organ 2003;81:367-72 (Pubitemid 36644263)
5. Shann F. Antipyretics in severe sepsis. Lancet 1995;345:338.
6. Schulman CI, Namias N, Doherty J, et al. The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized prospective study. Surg Infect (Larchmt) 2005;6:369-75 (Pubitemid 43263277)
7. Haupt MT, Jastremski MS, Clemmer TP, Metz CA, Goris GB. Effect of ibuprofen in patients with severe sepsis: a randomized, double-blind, multicenter study. The Ibuprofen Study Group. Crit Care Med 1991;19:1339-47
8. Bernard GR, Wheeler AP, Russell JA, et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med 1997;336:912-18
9. Graham NM, Burrell CJ, Douglas RM, Debelle P, Davies L. Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers. J Infect Dis 1990;162:1277-82
10. Stanley ED, Jackson GG, Panusarn C, Rubenis M, Dirda V. Increased virus shedding with aspirin treatment of rhinovirus infection. JAMA 1975;231:1248-51
11. Brandts CH, Ndjave M, Graninger W, Kremsner PG. Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet 1997;350:704-9 (Pubitemid 27371169)
12. Doran TF, De Angelis C, Baumgardner RA, Mellits ED. Acetaminophen: more harm than good for chickenpox? J Pediatr 1989;114:1045-8
13. Plaisance KI, Kudaravalli S, Wasserman SS, Levine MM, Mackowiak PA. Effect of antipyretic therapy on the duration of illness in experimental influenza A, Shigella sonnei and Rickettsia rickettsii infections. Pharmacotherapy 2000;20:1417-22
14. Sullivan-Bolyai JZ, Corey L. Epidemiology of Reye's syndrome. Epidemiol Rev 1981;3:1-26
15. Halpin TJ, Holtzhauer FJ, Campbell RJ, et al. Reye's syndrome and medication use. JAMA 1982;248:687-91
16. Daniels SR, Greenberg RS, Ibrahim MA. Scientific uncertainties in the studies of salicylate use and Reye's syndrome. JAMA 1983;249:1311-16
17. Bradburn MJ, Deeks JJ, Berlin JA, Russell Localio A. Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Stat Med 2007;26:53-77
18. Wang M, Bushman B. Integrating results through meta-analytic review using SAS software. Cary, NC: SAS Institute Inc.; 1999
19. Crocker JF, Digout SC, Lee SH, et al. Effects of antipyretics on mortality due to influenza B virus in a mouse model of Reye's syndrome. Clin Invest Med - Medecine Clinique et Experimentale 1998;21:192-202
20. Davis LE, Green CL, Wallace JM. Influenza B virus model of Reye's syndrome in mice: the effect of aspirin. Ann Neurol 1985;18:556-9
21. Sunden Y, Park CH, Matsuda K, et al. The effects of antipyretics on influenza virus encephalitis in mice and chicks. J Vet Med Sci 2003;65:1185-8 (Pubitemid 41380041)
22. Tomas E, Samuel I, Barnaure F. The effect of some drugs and of ceruloplasmin on experimental influenza APR 8/34 (H0N1) infection in the mouse. Virologie 1979;30:233-4 (Pubitemid 10208395)
23. Denys A, Pokrzeptowicz G. [Effect of aspirin and indocin on the course of influenza virus infection in mice]. Medycyna Doswiadczalna i Mikrobiologia 1970;22:169-74
24. Linnemann CC Jr, Ueda K, Hug G, Schaeffer A, Clark A, Schiff GM. Salicylate intoxication and influenza in ferrets. Pediatr Res 1979;13:44-7
25. Deshmukh DR, Maassab HF, Mason M. Interactions of aspirin and other potential etiologic factors in an animal model of Reye syndrome. Proc Natl Acad Sci USA 1982;79:7557-60 (Pubitemid 13179146)
26. Mukhopadhyay A, Sarnaik AP, Deshmukh DR. Interactions of ibuprofen with influenza infection and hyperammonemia in an animal model of Reye's syndrome. Pediatr Res 1992;31:258-60
27. Ryan PB, Rush DR, Nicholas TA, Graham DG. A double-blind comparison of fenoprofen calcium acetaminophen, and placebo in the palliative treatment of common nonbacterial upper respiratory infections. Curr Ther Res - Clin Exper 1987;41:17-23
28. Grebe W, Ionescu E, Gold MS, Liu JM, Frank WO. A multicenter randomized, double-blind, double-dummy, placebo- and active-controlled, parallel-group comparison of diclofenac-K and ibuprofen for the treatment of adults with influenza-like symptoms. Clin Ther 2003;25:444-58 (Pubitemid 36286912)
29. Gruber CM Jr, Collins T. Antipyretic effect of fenoprofen. J Med 1972;3:242-8
30. Breese Hall C, Dolin R, Gala CL. Children with influenza A infection: Treatment with rimantadine. Pediatrics 1987;80:275-82 (Pubitemid 17126807)
31. Younkin SW, Betts RF, Roth FK, Douglas RG Jr. Reduction in fever and symptoms in young adults with influenza A/Brazil/78 H1N1 infection after treatment with aspirin or amantadine. Antimicrob Agents Chemother 1983;23:577-82
32. Thompson J, Fleet W, Lawrence E, Pierce E, Morris L, Wright P. A comparison of acetaminophen and rimantadine in the treatment of influenza A infection in children. J Med Virol 1987;21:249-55 (Pubitemid 17038294)
33. Lerro SJ, Rapalski AJ, Schmerer F. Therapeutic comparison between aureomycin and APC in clinical influenza. United States Armed Forces Medical Journal 1958;9:479-86
34. Chu CM, Tian SF, Ren GF, Zhang YM, Zhang LX, Liu GQ. Occurrence of temperature-sensitive influenza A viruses in nature. J Virol 1982;41:353-9
35. Oxford JS, Corcoran T, Schild GC. Naturally occurring temperature-sensitive influenza A viruses of the H1N1 and H3N2 subtypes. J Gen Virol 1980;48:383-9 (Pubitemid 10014063)
36. Kung HC, Jen KF, Yuan WC, Tien SF, Chu CM. Influenza in China in 1977: recurrence of influenza virus A subtype H1N1. Bull World Health Organ 1978;56:913-18
37. Giesendorf B, Bosch FX, Wahn K, Rott R. Temperature sensitivity in maturation of mammalian influenza A viruses. Virus Research 1984;1:655-67 (Pubitemid 15195313)
38. Kendal AP, Galphin JC, Palmer EL. Replication of influenza virus at elevated temperatures: production of virus-like particles with reduced matrix protein content. Virology 1977;76:186-95
39. Dalton RM, Mullin AE, Amorim MJ, Medcalf E, Tiley LS, Digard P. Temperature sensitive influenza A virus genome replication results from low thermal stability of polymerase-cRNA complexes. Virol J 2006;3:58 (Pubitemid 44400834)
40. Roberts NJ Jr. Impact of temperature elevation on immunologic defenses. Rev Infect Dis 1991;13:462-72
41. Done AK. Treatment of fever in 1982: a review. Am J Med 1983;74:27-35
42. Manzella JP, Roberts NJ. Human macrophage and lymphocyte responses to mitogen stimulation after exposure to influenza virus, ascorbic acid, and hyperthermia. J Immunol 1979;123:1940-4
43. Hirai N, Hill NO, Osther K. Temperature influences on different human alpha interferon activities. J Interferon Res 1984;4:507-16 (Pubitemid 14023306)
44. Prymula R, Siegrist C-A, Chlibek R, et al. Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials. Lancet 2009;374:1339-50
45. Strouse S. Experimental studies on pneumococcus infections. J Exp Med 1909;11:743-61
46. Enders JF, Shaffer MF. Studies on natural immunity to pneumococcus Type III. J Exp Med 1936;64:7-18
47. Rich AR, McKee CM. The mechanism of a hitherto unexplained form of native immunity to the Type III pneumococcus. Bull Johns Hopkins Hospital 1936;59:171-207
48. Esposito AL. Aspirin impairs antibacterial mechanisms in experimental pneumococcal pneumonia. Am Rev Respir Dis 1984;130:857-62
49. Mackowiak PA, Ruderman AE, Martin RM, Many WJ, Smith JW, Luby JP. Effects of physiologic variations in temperature on the rate of antibiotic-induced bacterial killing. Am J Clin Pathol 1981;76:57-62
50. Klein MS, Conn CA, Kluger MJ. Behavioral thermoregulation in mice inoculated with influenza virus. Physiol Behav 1992;52:1133-9